C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/05/2002	US20020184656 In vivo assay system for screening and validation of drugs and other substances
12/05/2002	US20020184655 Generation of protein in urine that degrades or detoxifies preferential compounds; obtain transgenic animal, transform with vector that codes protein detectable in urine, express vector, recover protein
12/05/2002	US20020184201 Profile database and method for preparing profile
12/05/2002	US20020183934 Methods for making character strings, polynucleotides and polypeptides having desired characteristics
12/05/2002	US20020183933 Computer-aided techniques for analyzing biological sequences
12/05/2002	US20020183509 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same
12/05/2002	US20020183504 Isolated gene of given sequence, from the family of aspartate-specific cysteine proteases (ASCPs); involved in apoptosis
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183491 Methods for the isolation of proteinase inhibitor from potato tubers
12/05/2002	US20020183486 Nucleotide sequences coding enzymatic polypeptide for use in the generation of genetically engineered plants seeds; for use in animal feeds
12/05/2002	US20020183485 Nucleotide sequences coding receptor protein for use in the treatment of hypertriglyceridaemia, inflammation, cachexia, infections and tumors
12/05/2002	US20020183276 Administering alkaline phosphatase (TNAP) inhibitor to the tissue or patient effective to inhibit TNAP expression or activity for decreasing matrix mineralization in a tissue
12/05/2002	US20020183275 Obtaining a large cloned genomic fragment; using bacterial homologous recombination to genetically modify to create a large targeting vector for use in eukaryotic cells (LTVEC); introducing LTVEC into eukaryotic cells; quantitative assay
12/05/2002	US20020183274 Plant breedig; for producing hybrid seeds
12/05/2002	US20020183273 Compositions and methods for improving kidney function
12/05/2002	US20020183271 Administering to the patient a human MDA-7 polypeptide or a nucleic acid expressing the human MDA-7 polypeptide in eukaryotic cells, whereby the MDA-7 polypeptide inhibits angiogenesis in the patient
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183254 For inhibiting blood coagulation
12/05/2002	US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount
12/05/2002	US20020183250 For use in therapy of sleep disorders
12/05/2002	US20020183247 Lipoparticle comprising a protein and methods of making and using the same
12/05/2002	US20020182734 Transformation of preferential microorganism; obtain microorganism, incubate with preferential nucleotide sequences, transform microorganism, detect insertion of nucleotide sequences into chromosome
12/05/2002	US20020182733 Vector and methods of use for selective expression of genes in sites of angiogenesis in vivo
12/05/2002	US20020182732 Lentivirus vector for use as tool gene therapy
12/05/2002	US20020182731 Method for ligating nucleic acids and molecular cloning
12/05/2002	US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/05/2002	US20020182724 Expression vector for use tools in genome analysis and generation of transgenic animals
12/05/2002	US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors
12/05/2002	US20020182718 Method and device for the handling of samples and reagents
12/05/2002	US20020182709 Functional gene array in yeast
12/05/2002	US20020182708 Nucleotide sequence coding controlling polypeptide for use in the prevention of fungal infections
12/05/2002	US20020182707 Modified microbes
12/05/2002	US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins
12/05/2002	US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
12/05/2002	US20020182699 Nucleotide sequences coding enzymatic polypeptide for use in detergents
12/05/2002	US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/05/2002	US20020182697 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use
12/05/2002	US20020182691 Nucleotide sequences coding transport protein for use in nervous system disorders
12/05/2002	US20020182690 Nucleotide sequences coding enzymatic polypeptide for use in biosynthesis of polyhydroxyalkanoate materials
12/05/2002	US20020182689 Nucleotide sequences coding enzymatic polypeptide for use genration of amino acids
12/05/2002	US20020182688 Method for producing L-glutamic acid
12/05/2002	US20020182687 Generation of adaptor nucleotide sequence particles; obtain nucleotide sequences, incubate with adaptor, join, recover adaptor nucleotide sequences
12/05/2002	US20020182686 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences
12/05/2002	US20020182684 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders
12/05/2002	US20020182683 Vascular endothelial growth factor 2
12/05/2002	US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
12/05/2002	US20020182678 CD29 pig protein, nucleic acid coding for said protein, and applications thereof
12/05/2002	US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
12/05/2002	US20020182672 Amplification of preferential polypeptide in bacteria; obtain cells, transform with vector coding preferential polypetide, express vector, recover polypeptide
12/05/2002	US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders
12/05/2002	US20020182670 Modified factor VIII
12/05/2002	US20020182664 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components
12/05/2002	US20020182656 Methods for regulating vascularization using GEF containing NEK-like kinase (GNK)
12/05/2002	US20020182655 Method for identifying ligands for G protein-coupled receptors
12/05/2002	US20020182635 Methods of screening for LTRPC2 modulators
12/05/2002	US20020182626 Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications
12/05/2002	US20020182624 Chemokine receptors and disease
12/05/2002	US20020182620 Quantitative determination of nucleic acid amplification products
12/05/2002	US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182617 Binding assay using binding agents with tail groups
12/05/2002	US20020182615 All in one nucleic acid amplification assay
12/05/2002	US20020182614 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
12/05/2002	US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect
12/05/2002	US20020182608 Providing a device for detecting presence of target nucleic acid molecule; contacting probes with sample which may have target nucleic acid molecule under selective hybridization conditions, determining if electrical current can be carried
12/05/2002	US20020182605 Determining which of angiotensin receptor 1 (AGTR1) gene halotypes defines one copy of individual's AGTR1 gene wherein each of the AGTR1 haplotypes comprises a set of polymorphisms
12/05/2002	US20020182602 Biopolymer for use in the detection of preerential sequences in sample
12/05/2002	US20020182601 Method and reagents for analyzing the nucleotide sequence of nucleic acids
12/05/2002	US20020182598 Digesting a DNA sample with a restriction endonuclease; ligating a double stranded Amp- probe to each end of the fragmented DNA; separating excess unligated Amp-probe; denaturing the DNA fragments; amplification
12/05/2002	US20020182597 Used for screening for protein-compound interactions such as protein- therapeutic compound interactions
12/05/2002	US20020182595 Detection of proteins that bind to regulatory sequences; obtain nucleotide sequences, incubate with protein, detect bound nucleotide sequences
12/05/2002	US20020182593 Strawberry vein banding virus (SVBV) promoter
12/05/2002	US20020182592 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/05/2002	US20020182586 Novel compositions and methods for cancer
12/05/2002	US20020182258 Microparticles for delivery of nucleic acid
12/05/2002	US20020182228 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
12/05/2002	US20020182223 Eukaryotic double-stranded RNA expression vector comprising: (a) a designated DNA sequence of interest; and (b) a pair of promoters on opposite ends of the designated DNA oriented towards each other
12/05/2002	US20020182221 Recombinant papillomavirus vaccine and method for production and treatment
12/05/2002	US20020182219 Cancer immunotherapy
12/05/2002	US20020182218 Therapeutic anti-melanoma compounds
12/05/2002	US20020182211 Binds CD80 and/or CD86; an alanine at position +29 is substituted with tyrosine, leucine, tryptophan, or threonine, and a leucine at position +104 is substituted with a glutamic acid
12/05/2002	US20020182208 Glycosylated antibody
12/05/2002	US20020182206 Treating an inflammatory disease by administrating a therapeutically effective amount of a PRO301, PRO362 or PRO245 antagonist, or fragment thereof.
12/05/2002	US20020182203 Stimulate dephosphorylation of DSP-15 substrates; used to identify antibodies and other agents that inhibit DSP-15 activity; modulate cell proliferation, differentiation and survival.
12/05/2002	US20020182200 Use in stem cell mobilization, neuronal protection, and regulating hematopoiesis; inhibiting destruction of hematopoietic progenitor cells resulting from chemotherapy
12/05/2002	US20020182198 Purified MANF polypeptide (mature astrocyte-derived neurotrophic factor) of given sequence
12/05/2002	US20020182192 Administering bone marrow cells to the mammal, such as allogeneic cells or autologous cells engineered to express dystrophin or other gene products
12/05/2002	US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin
12/05/2002	US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
12/05/2002	US20020182181 Generated from a bacteriophage; gene expression inhibition
12/05/2002	US20020182180 Method for inducing immunity to viruses
12/05/2002	US20020180572 Electromagnetic device and high-voltage generating device and method of producing electromagnetic device
12/05/2002	US20020179520 Multi-well microfiltration apparatus
12/05/2002	DE19934573C2 Verfahren zur Markierung von festen, flüssigen und gasförmigen Substanzen A method for marking solid, liquid and gaseous substances
12/05/2002	DE10127572A1 Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen Tools for diagnostics, molecular definition and therapy development of chronic inflammatory joint diseases
12/05/2002	DE10126164A1 Für das metD-gen kodierende Nukleotidsequenzen For the metD gene coding nucleotide sequences
12/05/2002	DE10114209A1 Ortsgerichtete Transformation durch Verwendung von Amplifikationsvektoren Site-directed transformation by using amplification vectors
12/05/2002	CA2616769A1 Compositions and methods of increasing stress tolerance in plants

1 ... 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 ... 4023